Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis

Shanshan Xu,Lixia Qiu,Liang Xu,Yali Liu,Jing Zhang
DOI: https://doi.org/10.1186/s13027-024-00578-3
2024-04-26
Infectious Agents and Cancer
Abstract:Hepatitis C patients with advanced fibrosis or cirrhosis are at high risk of developing hepatocellular carcinoma (HCC), even after sustained virological response (SVR). Clinical recommendations impose a significant burden on patients by recommending lifelong screening for HCC every six months. The goals of this study were to develop a nomogram that accurately stratifies risk of HCC and improve the screening approach that is currently in use.
oncology,immunology
What problem does this paper attempt to address?